Shields Raymond C, Tazelaar Henry D, Berry Gerald J, Cooper Leslie T
Department of Cardiology, Mayo Clinic, Rochester, MN 55905, USA.
J Card Fail. 2002 Apr;8(2):74-8. doi: 10.1054/jcaf.2002.32196.
Idiopathic giant cell myocarditis (GCM) is an uncommon cause of cardiac failure distinguished clinically from lymphocytic myocarditis by rapidly progressive heart failure, arrhythmias, and heart block. Unlike fulminant lymphocytic myocarditis, patients with fulminant cardiac failure caused by GCM may respond to certain immunosuppressive agents; however, right ventricular endomyocardial biopsy (EMB) is infrequently used to establish the diagnosis partly because the sensitivity of EMB for GCM is unknown. The purpose of this study was to estimate the sensitivity of right ventricular EMB for GCM in a referral population.
Twenty subjects (of 63 total) in the Multicenter Giant Cell Myocarditis Registry underwent both right ventricular EMB and heart pathology (HRTP) evaluation from apical wedge, explantation, or autopsy. The false-negative rate of right ventricular EMB was defined as the ratio of negative EMB to positive HRTP results. Ten of the 20 subjects were women. The mean age was 38 years (range, 16-53 years). Twelve (60%) subjects had a positive EMB and positive HRTP confirming GCM. Three (15%) had a negative EMB and positive HRTP for GCM. Five had a positive EMB and negative HRTP evaluation for GCM. The resulting sensitivity of EMB for GCM was 80% (12/15) with a positive predictive value of 71%. Assuming the 5 subjects with a positive EMB and negative HRTP are true positives, the sensitivity improves to 85% (17/20). Predictors of negative HRTP after positive EMB were time from symptom onset to HRTP (P.006) and time from EMB to HRTP (P.03).
The sensitivity of right ventricular EMB is high in patients with GCM who have early disease presentation and a fulminant clinical course. Although these results may not apply to individuals with less aggressive disease, EMB may be used selectively to distinguish fulminant heart failure caused by GCM from other causes in which the prognosis may differ.
特发性巨细胞性心肌炎(GCM)是导致心力衰竭的一种罕见病因,在临床上与淋巴细胞性心肌炎的区别在于心力衰竭进展迅速、心律失常和心脏传导阻滞。与暴发性淋巴细胞性心肌炎不同,由GCM引起的暴发性心力衰竭患者可能对某些免疫抑制剂有反应;然而,右心室心内膜活检(EMB)很少用于确诊,部分原因是EMB对GCM的敏感性尚不清楚。本研究的目的是评估在转诊人群中右心室EMB对GCM的敏感性。
多中心巨细胞性心肌炎登记处的63名受试者中有20名接受了右心室EMB和心脏病理(HRTP)评估,评估取材于心尖楔形组织、心脏外植组织或尸检组织。右心室EMB的假阴性率定义为EMB结果阴性与HRTP结果阳性的比率。20名受试者中有10名女性。平均年龄为38岁(范围16 - 53岁)。12名(60%)受试者EMB结果阳性且HRTP结果阳性,确诊为GCM。3名(15%)受试者EMB结果阴性但HRTP结果阳性,诊断为GCM。5名受试者EMB结果阳性但HRTP评估结果阴性,诊断为GCM。由此得出EMB对GCM的敏感性为80%(12/15),阳性预测值为71%。假设5名EMB结果阳性但HRTP结果阴性的受试者为真正的阳性病例,则敏感性提高到85%(17/20)。EMB结果阳性后HRTP结果为阴性的预测因素是症状出现至HRTP的时间(P<0.006)和EMB至HRTP的时间(P<0.03)。
对于疾病早期表现且临床过程为暴发性的GCM患者,右心室EMB的敏感性较高。尽管这些结果可能不适用于病情较轻的个体,但EMB可用于有选择地鉴别由GCM引起的暴发性心力衰竭与其他预后可能不同的病因。